Balanced news tone
News Sentiment
ADXN sentiment intelligence
Addex Therapeutics Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
18 relevant articles
Price is moving more forcefully than the current news tone suggests.
89/100 classification confidence.
directly relevant articles
high-authority source matches
+12.2% over one week, -2.5% over four weeks, trend inactive, and below fair value.
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
89/100 classification
One-week reaction
12.2%
Price confirming higher
Trend fit
Trend inactive
-2.5% over four weeks
Fair value
-27.8%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
15
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GlobeNewswire
Direct company coverage
Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Jun 2026 05:00
- Source
- GlobeNewswire
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Earnings Forecast: Future EPS & Revenue Growth Estimates
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Institutional Confidence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Valuation: PE, PB & Fair Value Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Financial Health: Profitability & Balance Sheet Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Risk Assessment: Volatility, Financial Risk & Investment Risk
- Tone
- Negative 5/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 01:05
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Jun 2026 00:54
- Source
- TradingKey
TradingKey
Direct company coverage
Addex Therapeutics Ltd (ADXN) Shareholder Structure: Major Shareholders & Institutional Holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 00:19
- Source
- TradingKey
TradingKey
Direct company coverage
ADXN|Addex Therapeutics Ltd|Price:6.450|Chg%:-0.12
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- TradingKey
newsline.com
Direct company coverage
Addex Therapeutics (ADXN) Holds Steady – Consolidation Near Support May Signal Next Move - Short Setup Alerts
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 16:33
- Source
- newsline.com
Stock Titan
Direct company coverage
Addex Therapeutics (NASDAQ: ADXN) details 2026 AGM items and votes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Stock Titan
GlobeNewswire
Direct company coverage
Addex Convenes Annual General Meeting 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- GlobeNewswire
GuruFocus
Direct company coverage
Addex Therapeutics (ADXN) Regains Rights to ADX71149 After Janss
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2025 07:00
- Source
- GuruFocus
GlobeNewswire
Direct company coverage
Addex and Perceptive Launch Neurosterix with $63 Million to
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2024 07:00
- Source
- GlobeNewswire
MarketBeat
Direct company coverage
Addex Therapeutics (ADXN) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Sep 2020 02:53
- Source
- MarketBeat
TradingView
Direct company coverage
Technical Analysis of Addex Therapeutics Ltd (SIX:ADXN)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2018 07:37
- Source
- TradingView